Received Sep 5, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMR | MEASLES + MUMPS + RUBELLA (MMR II) | MERCK & CO. INC. | UNK | — | OT |
a MMR II vaccine was inadvertently administered to a patient via IV; No additional AE/PQC reported.; This spontaneous report was received from a pharmacist referring to a patient of unknown age and gender. The patient's medical history, historical drugs, past drug reactions or allergies, concurrent conditions, and concomitant drugs were not reported. On an unknown date, the patient was vaccinated with Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II) inadvertently via intravenous (IV) for prophylaxis (wrong route). No additional adverse event (AE) was reported (no adverse event). This is a non-valid case due to unknown patient.
sterile diluent